Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · IEX Real-Time Price · USD
1.055
+0.045 (4.46%)
Jul 26, 2024, 3:59 PM EDT - Market closed
Oragenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.02 | 0.04 | 0.13 | 0.09 | - | - | Upgrade
|
| Revenue Growth (YoY) | -84.54% | -71.37% | 51.20% | - | - | - | Upgrade
|
| Cost of Revenue | 14.48 | 15.49 | 10.07 | 10.59 | 22.11 | - | Upgrade
|
| Gross Profit | -14.46 | -15.45 | -9.94 | -10.5 | -22.11 | - | Upgrade
|
| Selling, General & Admin | 6 | 5.45 | 4.48 | 5.27 | 4.53 | 3.76 | Upgrade
|
| Research & Development | - | - | - | - | - | 12.12 | Upgrade
|
| Other Operating Expenses | - | - | - | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 6 | 5.45 | 4.48 | 5.27 | 4.54 | 15.88 | Upgrade
|
| Operating Income | -20.46 | -20.9 | -14.42 | -15.77 | -26.64 | -15.88 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.17 | 0.21 | 0.14 | 0.08 | 0.09 | 0.32 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | - | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.07 | 0.07 | 0.01 | 0 | 0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -20.26 | -20.66 | -14.29 | -15.71 | -26.56 | -15.57 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.13 | - | Upgrade
|
| Pretax Income | -20.26 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | Upgrade
|
| Earnings From Continuing Operations | -20.26 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | Upgrade
|
| Net Income | -20.26 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | Upgrade
|
| Net Income to Common | -20.26 | -20.66 | -14.29 | -15.71 | -26.43 | -15.57 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 2 | 2 | 2 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 2 | 2 | 2 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 30.13% | 11.97% | 3.40% | 106.24% | 33.69% | 224.29% | Upgrade
|
| EPS (Basic) | -7.74 | -9.18 | -7.11 | -8.09 | -28.05 | -22.09 | Upgrade
|
| EPS (Diluted) | -7.74 | -9.18 | -7.11 | -8.09 | -28.05 | -22.09 | Upgrade
|
| Free Cash Flow | -8.25 | -7.29 | -15.36 | -13.51 | -16.95 | -13.04 | Upgrade
|
| Free Cash Flow Per Share | -3.15 | -3.24 | -7.64 | -6.95 | -17.99 | -18.50 | Upgrade
|
| Operating Margin | -99181.69% | -55519.89% | -10964.61% | -18131.88% | - | - | Upgrade
|
| Free Cash Flow Margin | -39974.96% | -19363.34% | -11675.70% | -15535.76% | - | - | Upgrade
|
| EBITDA | -20.44 | -20.88 | -14.38 | -15.73 | -26.59 | -15.82 | Upgrade
|
| D&A For EBITDA | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | Upgrade
|
| EBIT | -20.46 | -20.9 | -14.42 | -15.77 | -26.64 | -15.88 | Upgrade
|
Source: S&P Capital IQ. Standard template.